Clinical Trial Update: Multi-Omics Integrative Analysis of Serum and Sputum to Uncover Key Determinants of Prognosis in Patients With ARDS

View source ↗

Summary

A clinical trial update for a planned multi-omics study using serum and sputum to identify prognostic determinants in Acute Respiratory Distress Syndrome (ARDS)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Snippet

Sponsor: Ruijin Hospital | Conditions: Acute Respiratory Distress Syndrome (ARDS), Microbiome Dysbiosis | Status: NOT_YET_RECRUITING